Allurion Technologies (ALUR) Return on Capital Employed (2023 - 2026)
Allurion Technologies (ALUR) posted Return on Capital Employed of 118.75% for Q1 2026, down 15.28% on a QoQ basis from 140.17% in Q4 2025, and up 35248.0% year-over-year from N/an in Q1 2025.
Allurion Technologies (ALUR) Return on Capital Employed (2023 - 2026) Analysis & Trends
Allurion Technologies' Return on Capital Employed history runs 4 years deep, the most recent figure standing at 118.75% for Q1 2026.
- Quarterly Return on Capital Employed rose 35248.0% year-over-year to 118.75% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 118.75% (up 35248.0% YoY) and the FY2025 annual result came in at 213.09%, up 36338.0% from the prior year.
- Return on Capital Employed was 118.75% for Q1 2026 at Allurion Technologies, down from 140.17% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 20640.43% in Q1 2024 and bottomed at 355.26% in Q3 2025.
- A 4-year average of 2458.32% and a median of 201.56% in 2025 frame the typical range for Return on Capital Employed.
- Peak annual rise in Return on Capital Employed reached 35942 bps in 2025, while the deepest fall reached 2087416 bps in 2025.
- Allurion Technologies' Return on Capital Employed stood at 256.98% in 2023, then gained by 15 bps to 219.25% in 2024, then surged by 164 bps to 140.17% in 2025, then fell by 15 bps to 118.75% in 2026.
- Business Quant data shows ALUR's Return on Capital Employed at 118.75% in Q1 2026, 140.17% in Q4 2025, and 355.26% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn | 118.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 118.75% |
| Dec 31, 2025 | 140.17% |
| Sep 30, 2025 | -355.26% |
| Jun 30, 2025 | -201.56% |
| Mar 31, 2025 | -233.73% |
| Dec 31, 2024 | -219.25% |
| Sep 30, 2024 | -200.18% |
| Jun 30, 2024 | -244.45% |
| Mar 31, 2024 | 20,640.43% |
| Dec 31, 2023 | -256.98% |
| Sep 30, 2023 | 7,853.56% |